Abstract
Purpose: To compare the radiation induced toxicity and loco regional recurrence rates along with tolerability of hypofractionated radiation therapy with conventional fractionation radiation therapy in post modified radical mastectomy carcinoma breast patients.
Material and Methods: Sixty post modified radical mastectomised, histopathologically proven patients of breast carcinoma from October 2016 to October 2017.Group I patients received 42.7Gy/16Fr/3.1 weeks and Group II patients received 50Gy/25Fr/5weeks. Radiation induced toxicities were assessed using RTOG and WHO criteria each week during treatment & fortnightly for 1st month after treatment & also up to 6 months after treatment.
Results: A total of 60 (30 in each group) patients completed treatment and 6 months follow-up. At the end of treatment grade I skin reactions were seen in 15(50%) patients of group I and 9 (30%) patients of Group II, Grade II in 10(33.3%) patients of Group I and 9(30%) patients in group II, Grade III in 1(3.3%) patients of group I and 0 patients of group II, no Grade IV reactions in any patients. Grade I esophageal reaction was seen in 10(33.3%) patients in both the groups, Grade II in 3(10%) patients of Group I and 0 patients of Group II, no patient in Group II. Nausea and vomiting (WHO TOXICITY CRITERIA) Grade I was seen in 16(53.3%) patients of Group I and 13(43.3%) patients of Group II, Grade II in 3(10%) patients of Group I and 1(3.3%) of Group II. Local recurrence along with distant metastasis was noted in 5 patients of Group I and distant metastasis only in 5 patients of Group II at median follow up of 14 months.
Conclusion: Radiation induced acute toxicity was more in group I (hypofractionation group) as compared to group II (Conventional fractionation group) while late toxicity was similar in both groups, thus making it equally tolerable schedule. Whereas compliance was better in group I due to shorter duration of treatment. Local recurrence was noted in hypofractionation group (I) patients and not in conventional group (II). Distant metastasis occurrence was equal in both the groups at median follow up of 14 months after treatment.
References
- Bray F, Ferlay J, Soerjomataram J, Siegel RL, Torre LA et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Canc J for Clin. 2018; 68(6).
- B.D. Sharma PGIMS, Rohtak (India): self compilation from Site wise distribution of cancer- data for the year 2018, retrieved Dec 2018 from Radiotherapy OPD Record section.
- Ali ME, Al Mageed AKM. Postmastectomy hypofractionation radiotherapy in breast cancer patients.Can and Onc Res. 2014; 2(7): 87-93.
- Lopez E, Guerrero R, Nunez MI, del Moral R, Villalobos M, Martinez-Galan J, et al. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. Breast Cancer Res. 2005;7(5):R690-8.
- Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331-41.
- Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371 (9618):1098-107.
- Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A et al; FAST-Forward Trial Management Group. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol. 2016 Jul;120(1):114-8.
- Kumbhaj PR, Sharma R, Saini PK, Patel PR. A study of two different dose fractionation schedules of post mastectomy chest wall irradiation in carcinoma breast patients. Int J Med Sci Public Health. 2013;2(4):1001-5.
- El-Sayed MI, Abdel-Wanis ME. Comparison of Hypofractionated and Conventional Radiotherapy Protocols in Breast Cancer Patients: A Retrospective Study. J Cancer Sci Ther. 2012;4(9):158-63.
- Eldeeb H, Awad I, Elhanafy O. Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up. Med Oncol. 2012 Dec;29(4):2570-6.
- Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. The Lancet. 2011; 378(9804):1707–16.
- Osako T, Oguchi M, Kumada M, Nemoto K, Iwase T, Yamashita T. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.Jpn J Clin Oncol.2008;38:334-8.
- Rastogi K, Jain S, Bhatnagar AR, Bhaskar S, Gupta S, Sharma N. A Comparative Study of Hypofractionated and Conve-ntional Radiotherapy in Postmastectomy Breast Cancer Patients. Asia Pac J Oncol Nurs. 2018;5(1):107-113.
Corresponding Author
Dr Roshani Vyas
Junior Resident, PGIMS, Rohtak, India
DOI: https://dx.doi.org/10.18535/jmscr/v7i1.44
